Crohn's Disease European Registry. A Prospective, Observational, Postmarketing Safety Surveillance Registry of Patients Treated With Remicade or Standard Therapy

Trial Profile

Crohn's Disease European Registry. A Prospective, Observational, Postmarketing Safety Surveillance Registry of Patients Treated With Remicade or Standard Therapy

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Oct 2014

At a glance

  • Drugs Infliximab (Primary)
  • Indications Crohn's disease
  • Focus Adverse reactions
  • Acronyms ENCORE
  • Sponsors Merck & Co; Schering-Plough
  • Most Recent Events

    • 01 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Jun 2012 Company added in association field as reported by ClinicalTrials.gov.
    • 10 Oct 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top